SecBot SecBot
6-K ·Filed Jun 24, 2026

MESO

MESOBLAST LTD
BULLISH
Impact 5/10
Horizonweeks Processed4mo ago SEC0001345099-26-000060
Notable filing: 6-K
Actionable Insight ▲ Bullish

The debt restructuring reduces short-term refinancing risk and improves balance sheet flexibility. Monitor for potential strategic partnership announcements given IP remains unencumbered. The fixed-rate long-term facility removes near-term financing overhang.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$14.50
T+0 close · Jun 24, 2026 · via day close
Latest settled
+4.34%
T+60 · $15.13
Vs SPY
+0.61%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 25 $14.50entry
  2. T+1 · 5mo ago −9.03%α −8.31% · $13.19
  3. T+5 · 5mo ago −2.83%α −4.39% · $14.09
  4. T+20 · 4mo ago +10.90%α +10.37% · $16.08
  5. T+60 · 8w ago +4.34%α +0.61% · $15.13
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Mesoblast drew down US$50 million from a five-year non-dilutive facility provided by director Dr. Gregory George, at a fixed 8.00% interest rate secured solely by the Temcell royalty. The company also held US$122 million cash as of March 30, 2026, and plans to retire higher-cost short-term debt from NovaQuest, strengthening its balance sheet for commercial operations and pipeline growth.

Key Facts

  • Drew down US$50 million from a five-year non-dilutive facility
  • Fixed interest rate of 8.00% per annum with five-year interest-only period
  • Facility secured solely by the Temcell royalty; no material assets or IP encumbered
  • US$122 million cash at March 30, 2026
  • Retiring higher-cost NovaQuest debt, eliminating short-term obligations
  • Existing shareholder and director Dr. Gregory George is the facility provider

Financial Impact

US$50 million drawn with US$122 million existing cash; retiring short-term high-cost debt improves capital structure.

debtcashinterest expense

Risk Factors

  • Fixed 8.00% interest adds US$4 million annual interest expense
  • Facility provider is a director, creating related-party concentration risk
  • Despite improved capital structure, cash burn for clinical/commercial activities remains

Market Snapshot

Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
90% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001345099-26-000060
Exhibit: exhibit99150mfacilitydra.htm0001345099-26-000060
Document: 0001345099-26-000060-index-headers.html0001345099-26-000060
Document: 0001345099-26-000060-index.html0001345099-26-000060
Document: 0001345099-26-000060.txt0001345099-26-000060

Track record

25 reports on MESO

Performance horizon

7 of 14 bullish or bearish reports moved the stock their way by T+1. Best: +24.95% at T+20 after the Jul 30, 2026 report. 9 of 14 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Neutral 2/10 Entry $13.25 Now $12.45 −6.04% settles Nov 17
  2. Nov 10, 20266d ago 6-K Neutral 3/10 Entry $13.65 to $13.10 Now $12.45 −8.79% ▼ −4.03% −3.68% vs SPY
  3. Nov 2, 202614d ago 6-K Neutral 2/10 Entry $14.77 to $14.29 Now $12.45 −15.71% ▼ −3.25% −4.90% vs SPY
  4. Oct 29, 202618d ago 6-K Bullish 6/10 No price data
  5. Oct 28, 202619d ago Press Release Bullish 6/10 Entry $15.67 to $15.16 Now $12.45 −20.55% ▼ −3.25% −1.48% vs SPY
  6. Oct 15, 20264w ago 6-K Bullish 6/10 Entry $13.28 to $11.95 Now $12.45 −6.25% ▼ −10.02% −10.44% vs SPY
  7. Oct 15, 20264w ago 6-K Neutral 2/10 Entry $13.95 to $13.28 Now $12.45 −10.75% ▼ −4.80% −3.70% vs SPY
  8. Oct 13, 20264w ago 6-K Mixed 6/10 Entry $13.90 to $13.79 Now $12.45 −10.40% ▼ −0.76% +0.33% vs SPY
  9. Sep 23, 20267w ago 6-K Neutral 3/10 Entry $15.48 to $15.12 Now $12.45 −19.57% ▼ −2.33% −2.87% vs SPY
  10. Aug 27, 202611w ago 20-F Bullish 6/10 Entry $18.18 to $17.44 Now $12.45 −31.52% ▼ −4.07% −3.84% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 25, 2026